from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1265/-

LFCtreatmentdescriptionclass of inhibitor

-0.329

Amikacinug/mL Amikacintranslation

0.145

Cap5-10ug/mL Capreomycintranslation

0.977

Rox10-50 ug/mL Roxithromycintranslation

-0.391

SM2-5 ug/mL Streptomycintranslation

0.423

Tet5-10 ug/mL Tetracyclinetranslation

-0.402

Rif0.2-5ug/mL Rifampicintranscription

-0.003

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.379

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.780

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.025

CPZ10-50 ug/mL Chlorpromazinerespiration

0.172

Clofazimine10-13 ug/mL Clofaziminerespiration

0.231

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.226

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.527

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.756

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.255

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.268

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.647

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.031

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.344

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.131

Nigericin50 uM Nigericinrespiration

0.626

TRC10-150 ug/mL Triclosanrespiration

0.561

TRZ10-25 ug/mL Thioridazinerespiration

-1.080

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.897

menadione6-10 ug/mL Menadionerespiration

-0.043

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.369

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.234

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.243

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.139

NRP_1Non-replicating persistence stage 1dosRassociated

-0.499

Amp0.2mg/mL AmpicillincellWall

-0.297

Cephalexin20-100 ug/mL CephalexincellWall

-0.104

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.724

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.382

EMB10-20 ug/mL EthambutolcellWall

-0.018

Eta12-40 ug/mL EthionamidecellWall

-0.389

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.016

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.282

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.590

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.042

BZA0.12 mg/mL BenzamidearomaticAmides

0.866

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

2.046

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.289

H2O24 mM hydrogen peroxideDNAdamaging

-0.382

Levo10 ug/mL LevofloxacinDNAdamaging

-0.493

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.078

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.465

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.633

UVUV-irradiationDNAdamaging

0.132

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.484

Antimycin12.5-50 ug/mL Antimycin A?

-0.739

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.238

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.277

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.697

PA8240.2-2 ug/mL PA-824?

1.148

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.002

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.685

Verapamil50 uM Verapamil?

-0.839

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.658

methoxatin10-20 ug/mL Methoxatin?